Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Agricultural Inputs

Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines primarily in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance imaging devices. In addition, the company offers consumer health products that are used as a daily health solution to treat minor illnesses, as well as sells and distributes hybrid seeds, such as corn and paddy. Further, it provides digital farming products comprising FarmRise and other digital applications, such as drones for spray services, etc., as well as provides various technologies, such as remote sensing, IoT sensors, GPS, artificial intelligence, and data analytics to monitor and manage crop growth, soil quality, weather patterns, and other factors. The company also exports its products. Bayer CropScience Limited was founded in 1863 and is based in Thane, India.

Revenue projections:

Revenue projections for BAYERCROP
Revenue projections for BAYERCROP

BAYERCROP is projected to experience a revenue decline compared to last year, a development that often leads to investor caution. The drop could negatively impact the company's bottom line, as lower revenues typically signal reduced profitability, prompting more conservative investment strategies.

Financial Ratios:

currentRatio 0.000000
forwardPE 28.443815
debtToEquity 3.266000
earningsGrowth 1.798000
revenueGrowth 0.047000
grossMargins 0.395060
operatingMargins 0.092480
trailingEps 149.280000
forwardEps 168.753740

BAYERCROP's Forward PE ratio suggests the stock price is reasonable in relation to earnings. It's not overpriced, providing room for future growth, making the stock a potentially valuable investment for those seeking long-term gains.
With a forward EPS greater than its trailing EPS, BAYERCROP is forecasted to be more profitable this year than last. This growth expectation reflects confidence in the company's earnings potential and suggests an improving financial trajectory for the year ahead.

Price projections:

Price projections for BAYERCROP
Price projections for BAYERCROP

The gradual downward revision of BAYERCROP's price projections signals decreasing confidence in the company's future performance. Analysts are adjusting their expectations, reflecting uncertainty about BAYERCROP's growth potential.

Recommendation changes over time:

Recommendations trend for BAYERCROP
Recommendations trend for BAYERCROP


The analysts' recent buy bias for Bayer CropScience Limited indicates strong confidence in the stock's future performance. This could encourage more investors to view Bayer CropScience Limited as a worthwhile investment, positioning the company as a top choice for those seeking financial security and long-term growth opportunities.